Container (Container)
Sorafenib Tablet, Film Coated
Product Images NDC 43598-458
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sorafenib (NDC 43598-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Figure1)
The text indicates data regarding a trial study of Sorafenib and Placebo for an unknown condition. Median survival times were 10.7 months for Sorafenib and 7.9 months for Placebo with an HR of 0.69 and a p-value of 0.00058, suggesting a statistically significant difference between the two groups. The remaining characters in the text do not provide any useful information.*
Figure3 (Figure3)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
